Correlation Between Imaging Features and REm18 Antibodies in Alveolar Echinococcosis: Results from a Multicenter Study in France

Overview

Journal Parasite

Date 2025 Feb 7

PMID 39918234

Authors

Gabriel Simon

Frederic Grenouillet

Carine Richou

Eric Delabrousse

Oleg Blagoskonov

Anne Minello

Gerard Thiefin

Emilia Frentiu

Martine Wallon

Solange Bresson-Hadni

Paul Calame

Affiliations

Soon will be listed here.

Abstract

Background: To correlate imaging features of alveolar echinococcosis (AE) with the antibodies to recombinant Em18 (rEm18AB) at diagnosis and evaluate initial imaging features associated with serologic response, this retrospective study used data from the prospective multicenter EchinoVISTA study (NCT02876146). Imaging and serology were performed at diagnosis and during follow-up. Univariate and multivariate analyses were used to evaluate imaging features associated with the rEm18AB index. Follow-up analyses evaluated the imaging features associated with serologic response (defined as a 50% reduction in the baseline value within 2 years) in non-operated patients treated with albendazole alone.

Results: From June 2012 to July 2016, 45 patients were included, with 8/45 (18%) having an rEm18AB index < 1. Maximum lesion size (76 mm [IQR = 57-93] vs. 36 mm [IQR = 26-51], p = 0.006), microcyst percentage (70% [IQR = 3-8] vs. 20% [IQR = 0.5-3.5], p = 0.004), and maximum standardized uptake value (SUV) on fluorodeoxyglucose positron emission tomography (5.1 [IQR = 4.4-6.2] vs. 2.6 [IQR = 2.4-3.9], p = 0.001) were associated with an rEm18AB index > 1. In patients treated with albendazole, serologic responders at 2 years had smaller lesions (5.3 [IQR = 3.8-72] vs. 3.5 [IQR = 2.7-3.7], p = 0.010) with less pedicle involvement, and lower initial rEm18AB index (2.98 ± 1.63 vs. 7.81 ± 3.95, p = 0.011).

Conclusion: Maximum lesion size, percentage of microcysts within the lesion, and maximum lesion SUV are significant imaging features of AE correlated with the rEm18AB index. Serologic response at 2 years occurs primarily in patients with small lesions and a low rEm18AB index.

References

Piarroux M, Piarroux R, Knapp J, Bardonnet K, Dumortier J, Watelet J . Populations at risk for alveolar echinococcosis, France. Emerg Infect Dis. 2013; 19(5):721-8. PMC: 3647496. DOI: 10.3201/eid1905.120867. View

Ito A, Sako Y, Yamasaki H, Mamuti W, Nakaya K, Nakao M . Development of Em18-immunoblot and Em18-ELISA for specific diagnosis of alveolar echinococcosis. Acta Trop. 2003; 85(2):173-82. DOI: 10.1016/s0001-706x(02)00221-8. View

Calame P, Weck M, Busse-Cote A, Brumpt E, Richou C, Turco C . Role of the radiologist in the diagnosis and management of the two forms of hepatic echinococcosis. Insights Imaging. 2022; 13(1):68. PMC: 8994011. DOI: 10.1186/s13244-022-01190-y. View

Sako Y, Nakao M, Nakaya K, Yamasaki H, Gottstein B, Lightowers M . Alveolar echinococcosis: characterization of diagnostic antigen Em18 and serological evaluation of recombinant Em18. J Clin Microbiol. 2002; 40(8):2760-5. PMC: 120647. DOI: 10.1128/JCM.40.8.2760-2765.2002. View

Bresson-Hadni S, Spahr L, Chappuis F . Hepatic Alveolar Echinococcosis. Semin Liver Dis. 2021; 41(3):393-408. DOI: 10.1055/s-0041-1730925. View

Torgerson P, Keller K, Magnotta M, Ragland N . The global burden of alveolar echinococcosis. PLoS Negl Trop Dis. 2010; 4(6):e722. PMC: 2889826. DOI: 10.1371/journal.pntd.0000722. View

Bi X, Shao Y, Li L, Wang Y, Zhang C, Lu G . Evaluation of the diagnostic value of the immunoblotting and ELISA tests using recombinant Em18 antigen in human alveolar echinococcosis from Xingjiang China. Exp Ther Med. 2018; 16(4):3155-3160. PMC: 6125881. DOI: 10.3892/etm.2018.6555. View

Gruner B, Kern P, Mayer B, Grater T, Hillenbrand A, Barth T . Comprehensive diagnosis and treatment of alveolar echinococcosis: A single-center, long-term observational study of 312 patients in Germany. GMS Infect Dis. 2019; 5:Doc01. PMC: 6301735. DOI: 10.3205/id000027. View

Kodama Y, Fujita N, Shimizu T, Endo H, Nambu T, Sato N . Alveolar echinococcosis: MR findings in the liver. Radiology. 2003; 228(1):172-7. DOI: 10.1148/radiol.2281020323. View

10.

Reuter S, Nussle K, Kolokythas O, Haug U, Rieber A, Kern P . Alveolar liver echinococcosis: a comparative study of three imaging techniques. Infection. 2001; 29(3):119-25. DOI: 10.1007/s15010-001-1081-2. View

11.

Caoduro C, Porot C, Vuitton D, Bresson-Hadni S, Grenouillet F, Richou C . The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med. 2013; 54(3):358-63. DOI: 10.2967/jnumed.112.109942. View

12.

Brumpt E, Blagosklonov O, Calame P, Bresson-Hadni S, Vuitton D, Delabrousse E . AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity. Infection. 2019; 47(6):955-960. DOI: 10.1007/s15010-019-01328-z. View

13.

Hotz J, Peters L, Kapp-Schworer S, Theis F, Eberhardt N, Essig A . Evaluation of Serological Markers in Alveolar Echinococcosis Emphasizing the Correlation of PET-CTI Tracer Uptake with RecEm18 and -Specific IgG. Pathogens. 2022; 11(2). PMC: 8880252. DOI: 10.3390/pathogens11020239. View

14.

Charbonnier A, Knapp J, Demonmerot F, Bresson-Hadni S, Raoul F, Grenouillet F . A new data management system for the French National Registry of human alveolar echinococcosis cases. Parasite. 2014; 21:69. PMC: 4271653. DOI: 10.1051/parasite/2014075. View

15.

Bart J, Piarroux M, Sako Y, Grenouillet F, Bresson-Hadni S, Piarroux R . Comparison of several commercial serologic kits and Em18 serology for detection of human alveolar echinococcosis. Diagn Microbiol Infect Dis. 2007; 59(1):93-5. DOI: 10.1016/j.diagmicrobio.2007.03.018. View

16.

Ito A, Schantz P, Wilson J . Em18, a new serodiagnostic marker for differentiation of active and inactive cases of alveolar hydatid disease. Am J Trop Med Hyg. 1995; 52(1):41-4. DOI: 10.4269/ajtmh.1995.52.41. View

17.

Crouzet J, Grenouillet F, Delabrousse E, Blagosklonov O, Thevenot T, Di Martino V . Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up. Clin Microbiol Infect. 2009; 16(6):788-91. DOI: 10.1111/j.1469-0691.2009.02924.x. View

18.

Sako Y, Nakao M, Nakaya K, Yamasaki H, Ito A . Recombinant antigens for serodiagnosis of cysticercosis and echinococcosis. Parasitol Int. 2005; 55 Suppl:S69-73. DOI: 10.1016/j.parint.2005.11.011. View

19.

Husmann L, Deibel A, Skawran S, Ledergerber B, Muehlematter U, Hasse B . Follow-up PET/CT of alveolar echinococcosis: Comparison of metabolic activity and immunodiagnostic testing. PLoS One. 2022; 17(6):e0270695. PMC: 9242476. DOI: 10.1371/journal.pone.0270695. View

20.

Knapp J, Sako Y, Grenouillet F, Bresson-Hadni S, Richou C, Gbaguidi-Haore H . Comparison of the serological tests ICT and ELISA for the diagnosis of alveolar echinococcosis in France. Parasite. 2014; 21:34. PMC: 4111071. DOI: 10.1051/parasite/2014037. View